Contact us

877-469-1TRM
424-208-8866

Efficacy and Safety Study of Clonidine Lauriad™ to Treat Oral Mucositis

A Phase II, Multi-center, Randomised, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Clonidine Lauriad™ 50 μg and 100 μg Mucoadhesive Buccal Tablet (MBT) Applied Once Daily to Those of Placebo in the Prevention and Treatment of Chemoradiation Therapy Induced Oral Mucositis in Patients With Head and Neck Cancer

For more information, please visit ClinicalTrials.gov

Patient Population Investigational Product(s) Phase Status
Head and Neck Cancer Patients Receiving Chemo-Radiation Clonidine Lauriad II Open and Accruing